Reuters logo
BRIEF-Audentes says announces commencement of LUSTRO study
March 1, 2017 / 1:49 PM / 7 months ago

BRIEF-Audentes says announces commencement of LUSTRO study

March 1 (Reuters) - Audentes Therapeutics Inc

* Audentes Therapeutics - commencement of LUSTRO, study designed to characterize disease course in patients living with Crigler-Najjar syndrome Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below